Solazyme (NASDAQ: SZYM) had its price target increased by Raymond James from $10.50 to $12.50 in a research report sent to investors on Monday morning, Stock Ratings Network.com reports. The firm currently has an outperform rating on the stock.
A number of other analysts have also recently weighed in on SZYM. Analysts at Robert W. Baird raised their price target on shares of Solazyme from $10.00 to $12.00 in a research note to investors on Friday, May 10th. They now have an outperform rating on the stock. Analysts at Morgan Stanley initiated coverage on shares of Solazyme in a research note to investors on Friday, April 19th. They set an overweight rating on the stock.
Nine equities research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and an average price target of $12.63.
Shares of Solazyme (NASDAQ: SZYM) opened at 11.91 on Monday. Solazyme has a 52 week low of $6.45 and a 52 week high of $14.34. The stock’s 50-day moving average is currently $8.1. The company’s market cap is $736.4 million.
Solazyme, Inc. (NASDAQ: SZYM) makes oil.